For example, released eATP can ligate P2RX7 on dendritic cells to drive its recruitment and activation, which then generate adaptive anticancer immunity by the process of tumor-derived antigens and secretion of interleukin-1β[214]. The gene discussed is P2RX7; the disease is neoplasm.